Axsome Therapeutics (AXSM) Free Cash Flow Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 24.91% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 20.11% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.71% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -10.65% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 31.42% |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn | -52.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -52.32% |
| Dec 31, 2025 | 12.28% |
| Sep 30, 2025 | 26.89% |
| Jun 30, 2025 | 1.34% |
| Mar 31, 2025 | -9.97% |
| Dec 31, 2024 | 3.11% |
| Sep 30, 2024 | 11.53% |
| Jun 30, 2024 | -5.88% |
| Mar 31, 2024 | -25.27% |
| Dec 31, 2023 | -13.86% |
| Sep 30, 2023 | -50.72% |
| Jun 30, 2023 | -43.19% |
| Mar 31, 2023 | 36.75% |
| Dec 31, 2022 | -16.45% |
| Sep 30, 2022 | -29.01% |
| Jun 30, 2022 | -57.28% |
| Mar 31, 2022 | -51.25% |
| Dec 31, 2021 | -43.33% |
| Sep 30, 2021 | -65.90% |
| Jun 30, 2021 | -49.03% |
| Mar 31, 2021 | -59.65% |
| Dec 31, 2020 | -48.43% |
| Sep 30, 2020 | -34.65% |
| Jun 30, 2020 | -38.58% |
| Mar 31, 2020 | -51.93% |
| Dec 31, 2019 | -34.49% |
| Sep 30, 2019 | -29.64% |
| Jun 30, 2019 | -17.69% |
| Mar 31, 2019 | -33.88% |
| Dec 31, 2018 | -63.16% |
| Sep 30, 2018 | -45.38% |
| Jun 30, 2018 | -53.85% |
| Mar 31, 2018 | -78.91% |